Wu SG - Search Results

1

Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer.

Liu K, Li GQ, Li SQ, Chen XQ, Wu SG. Liu K, et al. Among authors: wu sg. Breast. 2025 Jan 2;79:103873. doi: 10.1016/j.breast.2025.103873. Online ahead of print. Breast. 2025. PMID: 39754792 Free article.

2

Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making.

Lian CL, Li GQ, Zhou P, Wang J, He ZY, Wu SG. Lian CL, et al. Among authors: wu sg. Breast. 2021 Oct;59:117-123. doi: 10.1016/j.breast.2021.06.009. Epub 2021 Jun 28. Breast. 2021. PMID: 34229126 Free PMC article.

3

Impact of the 21-gene recurrence score testing on chemotherapy selection and clinical outcomes in T3N0 luminal breast cancer.

Liu K, Li JY, Li GQ, He ZY, Wu SG. Liu K, et al. Among authors: wu sg. Expert Rev Anticancer Ther. 2024 Dec;24(12):1283-1291. doi: 10.1080/14737140.2024.2423683. Epub 2024 Nov 3. Expert Rev Anticancer Ther. 2024. PMID: 39469907

4

Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.

Li GQ, Yao J, Zhou P, Chen DX, Lian CL, Yang SP, Huang CH, Wu SG. Li GQ, et al. Among authors: wu sg. Clin Breast Cancer. 2022 Apr;22(3):279-287. doi: 10.1016/j.clbc.2021.11.003. Epub 2021 Nov 14. Clin Breast Cancer. 2022. PMID: 34896002 Free article.

5

Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer.

Li GQ, Yu Y, Zhang WW, Zhou P, Lian CL, He ZY, Wu SG. Li GQ, et al. Among authors: wu sg. BJS Open. 2022 Mar 8;6(2):zrac025. doi: 10.1093/bjsopen/zrac025. BJS Open. 2022. PMID: 35466375 Free PMC article.

6

Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.

Li GQ, Xie SJ, Wu SG, He ZY. Li GQ, et al. Among authors: wu sg. Front Endocrinol (Lausanne). 2023 Feb 16;14:1103949. doi: 10.3389/fendo.2023.1103949. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36875478 Free PMC article.

7

Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer.

Yang SP, Liu K, Li Y, Li GQ, Li JY, Lin YY, Wu SG. Yang SP, et al. Among authors: wu sg. Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):99-106. doi: 10.1080/14737159.2024.2301940. Epub 2024 Jan 5. Expert Rev Mol Diagn. 2024. PMID: 38166613

8

Patterns of distant metastasis and survival outcomes in de novo metastatic breast cancer according to age groups.

Liu K, Huang AL, Chen XQ, Wu SG. Liu K, et al. Among authors: wu sg. Front Endocrinol (Lausanne). 2024 May 1;15:1385756. doi: 10.3389/fendo.2024.1385756. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38752173 Free PMC article.

9

Tumor grade and progesterone receptor status in predicting benefit of chemotherapy in high genomic risk breast cancer.

Liu K, Chen GP, Chen XQ, Wu SG. Liu K, et al. Among authors: wu sg. Expert Rev Anticancer Ther. 2024 Oct;24(10):1021-1028. doi: 10.1080/14737140.2024.2393749. Epub 2024 Aug 22. Expert Rev Anticancer Ther. 2024. PMID: 39152692

10

21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.

Xie SJ, Wang RJ, Wu SG, Zhang FX. Xie SJ, et al. Among authors: wu sg. Breast. 2024 Apr;74:103679. doi: 10.1016/j.breast.2024.103679. Epub 2024 Feb 12. Breast. 2024. PMID: 38367283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters